A detailed history of Strategic Wealth Partners, Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Strategic Wealth Partners, Ltd. holds 166 shares of MRNA stock, worth $4,110. This represents 0.0% of its overall portfolio holdings.

Number of Shares
166
Previous 357 53.5%
Holding current value
$4,110
Previous $9,000 55.56%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$23.51 - $34.67 $4,490 - $6,621
-191 Reduced 53.5%
166 $4,000
Q2 2025

Aug 11, 2025

BUY
$23.65 - $28.54 $8,443 - $10,188
357 New
357 $9,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $9.69B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Strategic Wealth Partners, Ltd. Portfolio

Follow Strategic Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Strategic Wealth Partners, Ltd. with notifications on news.